Scribe Therapeutics Inc.

SCTX

SCTXScribe Therapeutics Inc. US flag

NASDAQ

16.79

USD

-0.38

- -

271.70MMarket Cap

Profitability (USD)

Profitability Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -
Return on Assets (%)	- -	-21.15
Return on Capital (%)	- -	- -
Return on Invested Capital (%)	- -	- -
Gross Margin (%)	100	100
EBITDA Margin (%)	-145.7	-44.93
Operating Margin (%)	-156.24	-50.94
Incremental Operating Margin (%)	- -	- -
Pretax Margin (%)	-137.02	-46.14
Profit Margin (%)	-174.32	-42.62
Net Income to Common Margin (%)	-174.32	-42.62
Effective Tax Rate (%)	- -	- -
Dvd Payout Ratio (%)	- -	- -
Sustainable Growth Rate (%)	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Debt	42	41
ST Debt	1	37
LT Debt	41	5
Total Debt/EBITDA	-1.04	-1.8
Net Debt/EBITDA	-0.55	-0.98
Total Debt/EBIT	-0.97	-1.59
Net Debt/EBIT	-0.51	-0.86
EBITDA to Interest Expense	-16.77	-9.61
EBITDA-CapEx/Interest Expense	-17.34	-10.14
EBIT to Interest Expense	-17.99	-10.89
Interest Expense	2	2
Common Equity/Total Assets	-98.35	-183.36
Long-Term Debt/Equity (%)	- -	- -
Long-Term Debt/Capital (%)	-48.18	-4.71
Long-Term Debt/Total Assets (%)	31.7	6.14
Total Debt/Equity (%)	-33.11	-28.89
Total Debt/Capital (%)	-49.51	-40.62
Total Debt/Total Assets (%)	32.57	52.96
Net Debt to Equity	-17.38	-15.72
Net Debt/Capital (%)	-22.6	-19.64
EBITDA	-40	-23
EBITDA-CapEx	-41	-24
Operating Income (Loss)	-43	-26

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Cash Ratio	3	0.84
Current Ratio	3.15	0.97
Quick Ratio	3.1	0.95
CFO/Avg Current Liab	- -	-0.87
Common Equity/Total Assets	-98.35	-183.36
Long-Term Debt/Equity (%)	- -	- -
Long-Term Debt/Capital (%)	-48.18	-4.71
Long-Term Debt/Total Assets (%)	31.7	6.14
Total Debt/Equity (%)	-33.11	-28.89
Total Debt/Capital (%)	-49.51	-40.62
Total Debt/Total Assets (%)	32.57	52.96
CFO/Total Liabilities	-17.82	-20.4
CFO/CapEx	-33.53	-35.57
Altman's Z-Score	-1.67	-3.3

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -
Days Sales Outstanding	- -	- -
Inventory Turnover	- -	- -
Days Inventory Outstanding	- -	- -
Accounts Payable Turnover	- -	- -
Accounts Payable Turnover Days	- -	- -
Cash Conversion Cycle	- -	- -
Inventory to Cash Days	- -	- -
Inventories	- -	- -
Raw Materials	- -	- -
Work In Process	- -	- -
Finished Goods	- -	- -
Other Inventory	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Market Capitalization	- -	- -
- Cash & Cash Equivalents	13	13
+ Preferred Equity and Hybrid Capital	- -	- -
+ Minority/Non Controlling Interest	- -	- -
+ Total Debt	42	41
Enterprise Value	-63	-17
Total Capital	-84	-102
Total Debt/Capital (%)	-49.51	-40.62
Total Debt / EV	-0.66	-2.51
EV/Sales	- -	- -
EV/EBITDA	- -	- -
EV/EBIT	- -	- -
EV/Cash Flow to Firm	- -	- -
EV/Free Cash Flow to Firm	- -	- -
Diluted Market Cap	- -	- -
Diluted Enterprise Value	29	29
EV per Share	- -	- -
TTM Sales	27	51
TTM EBITDA	-40	-23
TTM Operating Income	-43	-26
TTM Cash Flow to Firm	-42	-43
TTM Free Cash Flow to Firm	-41	-42

Multiples (USD)

Valuation Multiples API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -
EV/EBIT	- -	- -
Enterprise Value	-63	-17
Low Price	- -	- -
EV/Sales	- -	- -
EV/EBITDA	- -	- -
Price/Earnings	- -	- -
Price/Earnings Average	- -	- -
Price/Earnings High	- -	- -
Price/Earnings Low	- -	- -
Price/Book Value	- -	- -
Price/Book Value Average	- -	- -
Price/Book Value High	- -	- -
Price/Book Value Low	- -	- -
Price/Tangible Book Value	- -	- -
Price/Tangible Book Value Average	- -	- -
Price/Tangible Book Value High	- -	- -
Price/Tangible Book Value Low	- -	- -
Price/Sales	- -	- -
Price/Sales Average	- -	- -
Price/Sales High	- -	- -
Price/Sales Low	- -	- -
Price/Cash Flow	- -	- -
Price/Cash Flow Average	- -	- -
Price/Cash Flow High	- -	- -
Price/Cash Flow Low	- -	- -
Price/Free Cash Flow Average	- -	- -
Price/Free Cash Flow High	- -	- -
Price/Free Cash Flow Low	- -	- -
EV/Sales Average	1.06	0.56
EV/Sales High	1.06	0.56
EV/Sales Low	1.06	0.56
EV/EBITDA Average	-0.73	-1.25
EV/EBITDA High	-0.73	-1.25
EV/EBITDA Low	-0.73	-1.25
EV/EBIT Average	-0.68	-1.1
EV/EBIT High	-0.68	-1.1
EV/EBIT Low	-0.68	-1.1
Last Price	- -	- -
High Price	- -	- -
Enterprise Value Average	29	29
Enterprise Value High	29	29
Enterprise Value Low	29	29

Profitability (USD)

Profitability Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -
Return on Assets (%)	- -	-21.15
Return on Capital (%)	- -	- -
Return on Invested Capital (%)	- -	- -
Gross Margin (%)	100	100
EBITDA Margin (%)	-145.7	-44.93
Operating Margin (%)	-156.24	-50.94
Incremental Operating Margin (%)	- -	- -
Pretax Margin (%)	-137.02	-46.14
Profit Margin (%)	-174.32	-42.62
Net Income to Common Margin (%)	-174.32	-42.62
Effective Tax Rate (%)	- -	- -
Dvd Payout Ratio (%)	- -	- -
Sustainable Growth Rate (%)	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Debt	42	41
ST Debt	1	37
LT Debt	41	5
Total Debt/EBITDA	-1.04	-1.8
Net Debt/EBITDA	-0.55	-0.98
Total Debt/EBIT	-0.97	-1.59
Net Debt/EBIT	-0.51	-0.86
EBITDA to Interest Expense	-16.77	-9.61
EBITDA-CapEx/Interest Expense	-17.34	-10.14
EBIT to Interest Expense	-17.99	-10.89
Interest Expense	2	2
Common Equity/Total Assets	-98.35	-183.36
Long-Term Debt/Equity (%)	- -	- -
Long-Term Debt/Capital (%)	-48.18	-4.71
Long-Term Debt/Total Assets (%)	31.7	6.14
Total Debt/Equity (%)	-33.11	-28.89
Total Debt/Capital (%)	-49.51	-40.62
Total Debt/Total Assets (%)	32.57	52.96
Net Debt to Equity	-17.38	-15.72
Net Debt/Capital (%)	-22.6	-19.64
EBITDA	-40	-23
EBITDA-CapEx	-41	-24
Operating Income (Loss)	-43	-26

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Cash Ratio	3	0.84
Current Ratio	3.15	0.97
Quick Ratio	3.1	0.95
CFO/Avg Current Liab	- -	-0.87
Common Equity/Total Assets	-98.35	-183.36
Long-Term Debt/Equity (%)	- -	- -
Long-Term Debt/Capital (%)	-48.18	-4.71
Long-Term Debt/Total Assets (%)	31.7	6.14
Total Debt/Equity (%)	-33.11	-28.89
Total Debt/Capital (%)	-49.51	-40.62
Total Debt/Total Assets (%)	32.57	52.96
CFO/Total Liabilities	-17.82	-20.4
CFO/CapEx	-33.53	-35.57
Altman's Z-Score	-1.67	-3.3

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -
Days Sales Outstanding	- -	- -
Inventory Turnover	- -	- -
Days Inventory Outstanding	- -	- -
Accounts Payable Turnover	- -	- -
Accounts Payable Turnover Days	- -	- -
Cash Conversion Cycle	- -	- -
Inventory to Cash Days	- -	- -
Inventories	- -	- -
Raw Materials	- -	- -
Work In Process	- -	- -
Finished Goods	- -	- -
Other Inventory	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Market Capitalization	- -	- -
- Cash & Cash Equivalents	13	13
+ Preferred Equity and Hybrid Capital	- -	- -
+ Minority/Non Controlling Interest	- -	- -
+ Total Debt	42	41
Enterprise Value	-63	-17
Total Capital	-84	-102
Total Debt/Capital (%)	-49.51	-40.62
Total Debt / EV	-0.66	-2.51
EV/Sales	- -	- -
EV/EBITDA	- -	- -
EV/EBIT	- -	- -
EV/Cash Flow to Firm	- -	- -
EV/Free Cash Flow to Firm	- -	- -
Diluted Market Cap	- -	- -
Diluted Enterprise Value	29	29
EV per Share	- -	- -
TTM Sales	27	51
TTM EBITDA	-40	-23
TTM Operating Income	-43	-26
TTM Cash Flow to Firm	-42	-43
TTM Free Cash Flow to Firm	-41	-42

Multiples (USD)

Valuation Multiples API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -
EV/EBIT	- -	- -
Enterprise Value	-63	-17
Low Price	- -	- -
EV/Sales	- -	- -
EV/EBITDA	- -	- -
Price/Earnings	- -	- -
Price/Earnings Average	- -	- -
Price/Earnings High	- -	- -
Price/Earnings Low	- -	- -
Price/Book Value	- -	- -
Price/Book Value Average	- -	- -
Price/Book Value High	- -	- -
Price/Book Value Low	- -	- -
Price/Tangible Book Value	- -	- -
Price/Tangible Book Value Average	- -	- -
Price/Tangible Book Value High	- -	- -
Price/Tangible Book Value Low	- -	- -
Price/Sales	- -	- -
Price/Sales Average	- -	- -
Price/Sales High	- -	- -
Price/Sales Low	- -	- -
Price/Cash Flow	- -	- -
Price/Cash Flow Average	- -	- -
Price/Cash Flow High	- -	- -
Price/Cash Flow Low	- -	- -
Price/Free Cash Flow Average	- -	- -
Price/Free Cash Flow High	- -	- -
Price/Free Cash Flow Low	- -	- -
EV/Sales Average	1.06	0.56
EV/Sales High	1.06	0.56
EV/Sales Low	1.06	0.56
EV/EBITDA Average	-0.73	-1.25
EV/EBITDA High	-0.73	-1.25
EV/EBITDA Low	-0.73	-1.25
EV/EBIT Average	-0.68	-1.1
EV/EBIT High	-0.68	-1.1
EV/EBIT Low	-0.68	-1.1
Last Price	- -	- -
High Price	- -	- -
Enterprise Value Average	29	29
Enterprise Value High	29	29
Enterprise Value Low	29	29

Shares Outstanding	18	18
Diluted Weighted Avg Shares	- -	- -
Basic Weighted Avg Shares	- -	- -
Revenue per Share	- -	- -
EBITDA per Share	- -	- -
Operating Income per Share	- -	- -
Basic EPS, GAAP	- -	- -
Basic EPS from Cont Ops	- -	- -
Diluted EPS, GAAP	- -	- -
Diluted EPS from Cont Ops	- -	- -
Dividend per Share	- -	- -
Cash Flow per Share	- -	- -
Free Cash Flow per Basic Share	- -	- -
Cash & Equivalents per Share	5.98	3.3
Book Value per Share	-7.16	-8.16
Tangible Book Value per Share	-7.16	-8.16

Scribe Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)